PAMU
PBYI icon

Pictet Asset Management (UK)’s Puma Biotechnology PBYI Stock Holding History

Pictet Asset Management (UK)’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-118,800
Closed -$4.61M – 1041
2019
Q1 		$4.61M Buy
118,800
+41,300
+53% +$1.26M 0.01% 720
2018
Q4 		$1.58K Sell
77,500
-341,986
-82% -$10.3M ﹤0.01% 856
2018
Q3 		$19.2M Buy
419,486
+93,865
+29% +$4.53M 0.04% 425
2018
Q2 		$19.3M Buy
325,621
+37,141
+13% +$2.15M 0.05% 403
2018
Q1 		$19.6M Buy
+288,480
New +$21.6M 0.05% 384
2015
Q4 		– Sell
-10,470
Closed -$789K – 862
2015
Q3 		$789K Buy
10,470
+220
+2% +$20.8K ﹤0.01% 803
2015
Q2 		$929K Buy
+10,250
New +$1.86M ﹤0.01% 806

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return